Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 745295, 14 pages
http://dx.doi.org/10.1155/2013/745295
Research Article

Saikosaponin-d Enhances the Anticancer Potency of TNF- via Overcoming Its Undesirable Response of Activating NF-Kappa B Signalling in Cancer Cells

1State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau, China
2Shum Yiu Foon Shum Bik Chuen Memorial Centre for Cancer and Inflammation Research, School of Chinese Medicine, Hong Kong Baptist University, 7 Baptist University Road, Kowloon Tong, Hong Kong
3Department of Biology, Hong Kong Baptist University, Hong Kong

Received 8 January 2013; Accepted 7 February 2013

Academic Editor: Shuang-En Chuang

Copyright © 2013 Vincent Kam Wai Wong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. S. Drutskaya, G. A. Efimov, A. A. Kruglov, D. V. Kuprash, and S. A. Nedospasov, “Tumor necrosis factor, lymphotoxin and cancer,” IUBMB Life, vol. 62, no. 4, pp. 283–289, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Hsu, J. Xiong, and D. V. Goeddel, “The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation,” Cell, vol. 81, no. 4, pp. 495–504, 1995. View at Google Scholar · View at Scopus
  3. H. Hsu, H. B. Shu, M. G. Pan, and D. V. Goeddel, “TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways,” Cell, vol. 84, no. 2, pp. 299–308, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. M. J. Morgan and Z. G. Liu, “Reactive oxygen species in TNFα-induced signaling and cell death,” Molecules and Cells, vol. 30, no. 1, pp. 1–12, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Pennica, G. E. Nedwin, J. S. Hayflick et al., “Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin,” Nature, vol. 312, no. 5996, pp. 724–729, 1984. View at Google Scholar · View at Scopus
  6. P. G. Brouckaert, G. G. Leroux-Roels, Y. Guisez, J. Tavernier, and W. Fiers, “In vivo anti-tumour activity of recombinant human and murine TNF, alone and in combination with murine IFN-γ, on a syngeneic murine melanoma,” International Journal of Cancer, vol. 38, no. 5, pp. 763–769, 1986. View at Google Scholar · View at Scopus
  7. F. R. Balkwill, A. Lee, G. Aldam et al., “Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons,” Cancer Research, vol. 46, no. 8, pp. 3990–3993, 1986. View at Google Scholar · View at Scopus
  8. J. P. Deroose, A. M. Eggermont, A. N. van Geel et al., “Long-term results of tumor necrosis factor alpha- and melphalan-based isolated limb perfusion in locally advanced extremity soft tissue sarcomas,” Journal of Clinical Oncology, vol. 29, no. 30, pp. 4036–4044, 2011. View at Google Scholar
  9. J. P. Deroose, A. M. Eggermont, A. N. van Geel, J. H. de Wilt, J. W. Burger, and C. Verhoef, “20 years experience of TNF-based isolated limb perfusion for in-transit melanoma metastases: TNF dose matters,” Annals of Surgical Oncology, vol. 19, no. 2, pp. 627–635, 2012. View at Google Scholar
  10. D. J. Grünhagen, J. H. W. de Wilt, A. N. Van Geel, C. Verhoef, and A. M. M. Eggermont, “Isolated limb perfusion with TNF-α and melphalan in locally advanced soft tissue sarcomas of the extremities,” Recent Results in Cancer Research, vol. 179, pp. 257–270, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Lucas, M. Kresse, M. Latta, and A. Wendel, “Tumor necrosis factor: How to make a killer molecule tumor-specific?” Current Cancer Drug Targets, vol. 5, no. 6, pp. 381–392, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. B. B. Aggarwal, “Nuclear factor-κB: the enemy within,” Cancer Cell, vol. 6, no. 3, pp. 203–208, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. B. B. Aggarwal, S. C. Gupta, and J. H. Kim, “Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey,” Blood, vol. 119, no. 3, pp. 651–665, 2012. View at Google Scholar
  14. F. Balkwill, “Tumour necrosis factor and cancer,” Nature Reviews Cancer, vol. 9, no. 5, pp. 361–371, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. B. B. Aggarwal, S. Shishodia, S. K. Sandur, M. K. Pandey, and G. Sethi, “Inflammation and cancer: how hot is the link?” Biochemical Pharmacology, vol. 72, no. 11, pp. 1605–1621, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Nakanishi and M. Toi, “Nuclear factor-κB inhibitors as sensitizers to anticancer drugs,” Nature Reviews Cancer, vol. 5, no. 4, pp. 297–309, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Karin, “Nuclear factor-κB in cancer development and progression,” Nature, vol. 441, no. 7092, pp. 431–436, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Tundis, M. Bonesi, B. Deguin et al., “Cytotoxic activity and inhibitory effect on nitric oxide production of triterpene saponins from the roots of Physospermum verticillatum (Waldst & Kit) (Apiaceae),” Bioorganic and Medicinal Chemistry, vol. 17, no. 13, pp. 4542–4547, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. V. K. W. Wong, H. Zhou, S. S. F. Cheung, T. Li, and L. Liu, “Mechanistic study of saikosaponin-d (Ssd) on suppression of murine T lymphocyte activation,” Journal of Cellular Biochemistry, vol. 107, no. 2, pp. 303–315, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Y. K. Yue, E. P. Y. Leung, N. K. Mak, and R. N. S. Wong, “A simplified method for quantifying cell migration/wound healing in 96-well plates,” Journal of Biomolecular Screening, vol. 15, no. 4, pp. 427–433, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. D. O. Moon, M. O. Kim, S. H. Kang, Y. H. Choi, and G. Y. Kim, “Sulforaphane suppresses TNF-α-mediated activation of NF-κB and induces apoptosis through activation of reactive oxygen species-dependent caspase-3,” Cancer Letters, vol. 274, no. 1, pp. 132–142, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Lee, M. H. Lee, Y. W. Kang, K. J. Rhee, T. U. Kim, and Y. S. Kim, “Parkin induces apoptotic cell death in TNF-alpha-treated cervical cancer cells,” BMB Reports, vol. 45, no. 9, pp. 526–531, 2012. View at Google Scholar
  23. W. Wang, J. N. Gallant, S. I. Katz et al., “Quinacrine sensitizes hepatocellular carcinoma cells to TRAIL and chemotherapeutic agents,” Cancer Biology and Therapy, vol. 12, no. 3, pp. 229–238, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. I. De Proost, I. Pintelon, I. Brouns et al., “Functional live cell imaging of the pulmonary neuroepithelial body microenvironment,” American Journal of Respiratory Cell and Molecular Biology, vol. 39, no. 2, pp. 180–189, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Zhong, R. E. Voll, and S. Ghosh, “Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300,” Molecular Cell, vol. 1, no. 5, pp. 661–671, 1998. View at Google Scholar · View at Scopus
  26. C. E. Malnou, T. Salem, F. Brockly, H. Wodrich, M. Piechaczyk, and I. Jariel-Encontre, “Heterodimerization with Jun family members regulates c-Fos nucleocytoplasmic traffic,” The Journal of Biological Chemistry, vol. 282, no. 42, pp. 31046–31059, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Yamamoto and R. B. Gaynor, “Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer,” The Journal of Clinical Investigation, vol. 107, no. 2, pp. 135–142, 2001. View at Google Scholar · View at Scopus
  28. A. B. Kunnumakkara, P. Anand, and B. B. Aggarwal, “Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins,” Cancer Letters, vol. 269, no. 2, pp. 199–225, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Shishodia and B. B. Aggarwal, “Diosgenin inhibits osteoclastogenesis, invasion, and proliferation through the downregulation of Akt, IκB kinase activation and NF-κB-regulated gene expression,” Oncogene, vol. 25, no. 10, pp. 1463–1473, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. F. C. M. Lopes, A. Rocha, A. Pirraco et al., “Anti-angiogenic effects of pterogynidine alkaloid isolated from Alchornea glandulosa,” BMC Complementary and Alternative Medicine, vol. 9, article 15, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. V. G. Gorgoulis, P. Zacharatos, A. Kotsinas et al., “p53 activates ICAM-1 (CD54) expression in an NF-κB-independent manner,” EMBO Journal, vol. 22, no. 7, pp. 1567–1578, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Vucic, M. C. Franklin, H. J. A. Wallweber et al., “Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP,” Biochemical Journal, vol. 385, no. 1, pp. 11–20, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. B. P. Eckelman and G. S. Salvesen, “The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases,” The Journal of Biological Chemistry, vol. 281, no. 6, pp. 3254–3260, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. B. P. Eckelman, G. S. Salvesen, and F. L. Scott, “Human inhibitor of apoptosis proteins: Why XIAP is the black sheep of the family,” EMBO Reports, vol. 7, no. 10, pp. 988–994, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. F. Li, E. J. Ackermann, C. F. Bennett et al., “Pleiotropic cell-division defects and apoptosis induced by interference with survivin function,” Nature Cell Biology, vol. 1, no. 8, pp. 461–466, 1999. View at Google Scholar · View at Scopus
  36. J. Ren, M. Shi, R. Liu et al., “The Birc6 (Bruce) gene regulates p53 and the mitochondrial pathway of apoptosis and is essential for mouse embryonic development,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 3, pp. 565–570, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Rothe, M. G. Pan, W. J. Henzel, T. M. Ayres, and D. V. Goeddel, “The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins,” Cell, vol. 83, no. 7, pp. 1243–1252, 1995. View at Publisher · View at Google Scholar · View at Scopus
  38. H. D. Shu, M. Takeuchi, and D. V. Goeddel, “The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 24, pp. 13973–13978, 1996. View at Google Scholar · View at Scopus
  39. Z. L. Chu, T. A. McKinsey, L. Liu, J. J. Gentry, M. H. Malim, and D. W. Ballard, “Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 19, pp. 10057–10062, 1997. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Irmler, M. Thome, M. Hahne et al., “Inhibition of death receptor signals by cellular FLIP,” Nature, vol. 388, no. 6638, pp. 190–195, 1997. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Polsky and C. Cordon-Cardo, “Oncogenes in melanoma,” Oncogene, vol. 22, no. 20, pp. 3087–3091, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Aggarwal, H. Ichikawa, Y. Takada, S. K. Sandur, S. Shishodia, and B. B. Aggarwal, “Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IκBα kinase and Akt activation,” Molecular Pharmacology, vol. 69, no. 1, pp. 195–206, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. S. P. Sasi, X. Yan, H. Enderling et al., “Breaking the “harmony” of TNF-alpha signaling for cancer treatment,” Oncogene, vol. 31, no. 37, pp. 4117–4127, 2012. View at Google Scholar
  44. N. Watanabe, Y. Niitsu, H. Sone et al., “Therapeutic effect of endogenous tumor necrosis factor on ascites meth a sarcoma,” Journal of Immunopharmacology, vol. 8, no. 2, pp. 271–283, 1986. View at Google Scholar · View at Scopus
  45. C. Y. Wang, D. C. Guttridge, M. W. Mayo, and A. S. Baldwin Jr., “NF-κb induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis,” Molecular and Cellular Biology, vol. 19, no. 9, pp. 5923–5929, 1999. View at Google Scholar · View at Scopus
  46. J. A. Sprowl, K. Reed, S. Armstrong et al., “Alterations in tumor necrosis factor signaling pathways are associated with cytotoxicity and resistance to taxanes: a study in isogenic resistant tumor cells,” Breast Cancer Research, vol. 14, article R2, 2012. View at Google Scholar
  47. D. C. Guttridge, C. Albanese, J. Y. Reuther, R. G. Pestell, and A. S. Baldwin Jr., “NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin D1,” Molecular and Cellular Biology, vol. 19, no. 8, pp. 5785–5799, 1999. View at Google Scholar · View at Scopus
  48. N. Taira, R. Mimoto, M. Kurata et al., “DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells,” The Journal of Clinical Investigation, vol. 2, no. 3, pp. 859–872, 2012. View at Google Scholar
  49. Y. L. Hsu, P. L. Kuo, L. C. Chiang, and C. C. Lin, “Involvement of p53, nuclear factor κb and Fas/Fas ligand in induction of apoptosis and cell cycle arrest by saikosaponin d in human hepatoma cell lines,” Cancer Letters, vol. 213, no. 2, pp. 213–221, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. G. P. Mognol, P. S. de Araujo-Souza, B. K. Robbs, L. K. Teixeira, and J. P. Viola, “Transcriptional regulation of the c-Myc promoter by NFAT1 involves negative and positive NFAT-responsive elements,” Cell Cycle, no. 5, pp. 1014–1028, 2012. View at Google Scholar
  51. A. Garg and B. B. Aggarwal, “Nuclear transcription factor-κB as a target for cancer drug development,” Leukemia, vol. 16, no. 6, pp. 1053–1068, 2002. View at Publisher · View at Google Scholar · View at Scopus
  52. H. Kausar, J. Jeyabalan, F. Aqil et al., “Berry anthocyanidins synergistically suppress growth and invasive potential of human non-small-cell lung cancer cells,” Cancer Letters, vol. 325, no. 1, pp. 54–62, 2012. View at Google Scholar
  53. L. M. Chen, C. H. Kuo, T. Y. Lai et al., “RANKL increases migration of human lung cancer cells through intercellular adhesion molecule-1 up-regulation,” Journal of Cellular Biochemistry, vol. 112, no. 3, pp. 933–941, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. R. Ramer, K. Bublitz, N. Freimuth et al., “Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1,” The FASEB Journal, vol. 26, no. 4, pp. 1535–1548, 2012. View at Google Scholar
  55. G. Gasparini, R. Longo, R. Sarmiento, and A. Morabito, “Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents?” Lancet Oncology, vol. 4, no. 10, pp. 605–615, 2003. View at Publisher · View at Google Scholar · View at Scopus
  56. A. M. Byrne, D. J. Bouchier-Hayes, and J. H. Harmey, “Angiogenic and cell survival functions of Vascular Endothelial Growth Factor (VEGF),” Journal of Cellular and Molecular Medicine, vol. 9, no. 4, pp. 777–794, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. J. W. Song and L. L. Munn, “Fluid forces control endothelial sprouting,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 37, pp. 15342–15347, 2011. View at Google Scholar
  58. X. L. Lu, S. X. He, M. D. Ren, Y. L. Wang, Y. X. Zhang, and E. Q. Liu, “Chemopreventive effect of saikosaponin-d on diethylinitrosamine-induced hepatocarcinogenesis: involvement of CCAAT/enhancer binding protein beta and cyclooxygenase-2,” Molecular Medicine Reports, vol. 5, no. 3, pp. 637–644, 2012. View at Google Scholar
  59. Q. Wang, X. L. Zheng, L. Yang et al., “Reactive oxygen species-mediated apoptosis contributes to chemosensitization effect of saikosaponins on cisplatin-induced cytotoxicity in cancer cells,” Journal of Experimental and Clinical Cancer Research, vol. 29, no. 1, article 159, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. G. C. Wu, H. Wu, L. Y. Fan, and H. F. Pan, “Saikosaponins: a potential treatment option for systemic lupus erythematosus,” Irish Journal of Medical Science, vol. 180, no. 1, pp. 259–261, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. J. X. Zheng, K. Q. Lu, D. G. Xia, G. R. Tian, and Z. J. Huang, “Therapeutic effects and mechanism of saikosaponin-d in mice with bleomycin-induced pulmonary fibrosis,” Zhonghua Yi Xue Za Zhi, vol. 90, no. 12, pp. 808–812, 2010. View at Google Scholar · View at Scopus
  62. S. J. Wu, K. W. Tam, Y. H. Tsai, C. C. Chang, and J. C. J. Chao, “Curcumin and saikosaponin A inhibit chemical-induced liver inflammation and fibrosis in rats,” American Journal of Chinese Medicine, vol. 38, no. 1, pp. 99–111, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. C. Wohlfarth and T. Efferth, “Natural products as promising drug candidates for the treatment of hepatitis B and C,” Acta Pharmacologica Sinica, vol. 30, no. 1, pp. 25–30, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. P. W. Cheng, L. T. Ng, L. C. Chiang, and C. C. Lin, “Antiviral effects of saikosaponins on human coronavirus 229E in vitro,” Clinical and Experimental Pharmacology and Physiology, vol. 33, no. 7, pp. 612–616, 2006. View at Publisher · View at Google Scholar · View at Scopus
  65. P. Li, Y. Gong, N. Zu, Y. Li, B. Wang, and F. Shimizu, “Therapeutic mechanism of Saikosaponin-d in anti-Thy1 mAb 1-22-3-induced rat model of glomerulonephritis,” Nephron. Experimental Nephrology, vol. 101, no. 4, pp. e111–e118, 2005. View at Google Scholar · View at Scopus